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DNA fragments correspondmg to the sequences of Exherlchw W/I tRNAz’S’ and amber suppressor tRNA”‘, were synthesized from overlapping 
oligonucleotides These were Interposed between a strong promotor and a synthetic transcriptional terminator to ensure the production of a 
transcript of the correct size The genes of promotor, fragment and terminator were cloned mto a conditional runaway replication plasmid. At 
temperatures below 37°C this vector has a low copy number but, followmg a temperature shift to 42°C. the copy number IS no longer regulated. 
Usmg these constructs an overexpression of tRNA”’ of about 20 times the level of the wild-type pool could be obtained (corresponding e g. to 
700 times the expression tRNA?‘“). From these systems 10 mg quantities of tRNA”‘s could be isolated with a serme acceptance of 1.100 pmoVAZ,, 
unit. 
Serine: tRNA: Aminoacyl-tRNA synthetase: Overexpression 
1. INTRODUCTION 
The specific recognition and interaction of ami- 
noacyl-tRNA synthetases with their cognate tRNAs are 
fundamental steps in the protein biosynthetic pathway 
and in maintaining the fidelity of translation. One route 
to the study of this at the molecular level is the analysis 
by X-ray diffraction of crystals of the appropriate com- 
plex. Recently this has led to the description of these 
interactions for the glutaminyl complex of Eschrrichiu 
coli [l] and the aspartyl system of yeast [2]. The enzyme 
component of the former is an example of a class 1 
synthetase and that of the latter a class 2b synthetase 
[3,4]; in neither instance is a structure of the enzyme 
alone available. We have described the structure of 
seryl-tRNA synthetase from E. coli which is a class 2a 
synthetase [4,5] and wish to proceed to a structural 
analysis of the nucleoprotein complex. 
Since the determination of the crystallization condi- 
tions of a synthetase:tRNA complex might require rela- 
tively large quantities of pure tRNA species we have 
undertaken the cloning and overexpression of synthetic 
genes coding for E. coli serine-specific tRNAs, in order 
to obtain the complex of tRNA”’ with seryl-tRNA syn- 
thetase. We report here the results obtained for the 
tRNA2”” (ser U gene product) and the amber suppressor 
tRNA”“(supD gene product) [6]. 
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Abbreviur~ons. BAPPS. h’,N’-bis(3-aminopropyl)-piperazine substi- 
tuted Sepharose: BSA. bovine serum albumin: TBE. tris borate EDTA 
buffer: TCA. trichloroacetic acid. 
2. MATERIALS AND METHODS 
E. co/r strain TGl used IS an EcoK-derivative of JMlOl [7] with the 
genotype .rupE hsdD.5 t/u d (luc-proAB) F’ (traD 36,proAB’. IacP IucZ 
dMl5}. The vector pLJCl9 was from Boehringer, Plasmid pGFIB-1 
[8] was kindly provided by Jenmfer Normanly (Cahforma Institute of 
Technology) and plasmid pOU71 [9] by Colin Hughes (Cambridge 
University) All rddioactive chemicals were from Amersham. The se- 
quencing enzymes (RNases L12. Phy M, B c. and Tl) and T4 RNA 
ligase were from Pharmacta and ‘Stams All’ from Sigma 
N,N’-Bis(3-aminopropyl)-piperazine substituted Sepharose (BAPPS) 
was prepared as previously described [lo]. 
Oligonucleotides were synthesized on an Applied Biosystem 380 
DNA synthesizer. These ohgonucleotides were purified by electropho- 
resis on a 20% polyacrylamidel7 M urea gel. visualised by UV shadow- 
ing after ethidtum bromide staining, excised and eluted in sterile water 
overnight at 4°C. After phenol/chloroform extractions the DNA was 
precipitated with 100% ethanol, washed with 70% ethanol, dried and 
resuspended m sterile water 
Internal oligonucleotides (100 pmol) were phosphorylated in 50 
mM Tris-HCl pH 7 6. 10 mM MgCl,. 10 mM DTT, 1 mM spermidine, 
0.1 mM ATP, with 10 U of T4 polynucleotide kmase for 1 h at 37°C. 
The kinase was then mactivated by incubation at 65°C for 10 min. 
Oligonucleotides of the 5’ ends of the fragment were kept 
unphosphorylated to avoid the concatemerization of the assembled 
fragment during hgation A mixture of 2.5 pmol of each ohgonucleo- 
tide was heated to 95°C for 5 mm. then cooled slowly to room temper- 
ature over a period of 12 h. Ligation of hybridized ohgonucleottdes 
aas carried out m 50 mM Tris-HCl pH 7.8, 10 mM MgCI,, 50 mM 
NaCl. 1 mM ATP. 10 mM spermidine. 0 1 m@ml BSA with 2 5 U of 
TJ DNA hgase at 15°C for 15-18 h. Electrophoresis on a 12% non- 
denaturing TBE-buffered polyacrylamide gel showed that the major 
hgation product corresponded to that expected for the tRNA gene 
codmg fragment and was also used to purify this fragment. 
2.4 Construction of tRh’A I”’ 0rere.Ypreswq struns 
Different vectors were used to obtain overexpression of tRNA. 
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Plasnuds were cleaved by EcoRI and PstI and were combmed with the 
insert to give a weight ratio of 1O:l (insert/vector). Ligation was car- 
ried out under the conditions described above. The ligation mixture 
was used to transform competent E. co/i TGI cells. Screening of the 
transformants was done by plasmid DNA minipreparation [l 1] and 
restriction analvsis. The nlasmid DNA of the clone with an insert of 
the correct size-were then-sequenced by the cham termination method 
of Sanger et al. [12]. 
2 5. Overproductron andpurlficatlon of tRNA”” 
Overproduction of tRNA7 and amber suppressor tRNA”’ was 
carried out by growing 10 1 culture of overexpressing clone at 37°C 
in LB mechum supplemented with 50 mg/ml ampicillin to an As4” of 
1.5. Then 8 1 of LB Amp at 50°C were added. The culture was 
incubated further for 1.5 h at 44T, followed by 30 min at 37°C. The 
cells were harvested by laminar-flow filtration and centrifugation. 
To prepare unfractionated tRNA. wet cell paste (40-50 g) was lysed 
by Incubation for 30 nun in 125 ml of a buffer containing 63 mM Tris, 
50 mM HCI pH 7.6,l mM EDTA and 50 mg lysozyme. After addition 
of 4 ml of 4% sodium deoxycholate and adjusting to 10 mM MgC&. 
DNA was digested with 50 U of RNase-free DNase I. The lysate was 
made 30 mM in NH&l and then centrifuged for 40 mm at 20,000 x g. 
The supernatant was centrifuged for 2 h at 100,000 x g to eliminate 
nbosomes. The supernatant from this was extracted twice with an 
equal volume of phenol saturated with buffer (10 mM Tris-HCl pH 
8, I mM EDTA) and finally with an equal volume of chloroform. The 
solution was made 0 3 M in sodium acetate pH 5.2 and precipitated 
overmght with one volume of ethanol. The recovered tRNA was 
resuspended m 10 ml 0.3 M sodium acetate pH 7. High molecular 
weight RNA was then precipitated by addition of l/2 volume of 
isopropanol and incubation at room temperature for 1 h. After centrif- 
ugation a further l/2 volume of isopropanol was added to the superna- 
tant and incubated 1 h at 0°C to precipitate tRNA. 
The precipitated tRNA was recovered by centrifugation, dissolved 
in 10 ml sterile water and applied to a BAPPS anion-exchanger column 
equilibrated with 1 M NaCl in 50 mM sodmm acetate pH 5 The 
column was developed with a linear gradient from 1 M to 1.2 M NaCl. 
and finally by a step of 2 M NaCl. Fractions with tRNA”’ acceptance 
activity were pooled and precipitated with ethanol. The tRNA”’ pool 
from the BAPPS column was made 1.5 M m ammonium sulfate and 
applied to an FPLC phenyl-Superose HR lo/IO column (Pharmacia). 
This was developed with a negative gradient from 1.8 M to 0.8 M 
ammonium sulfate m 10 mM ammonium acetate pH 6.5. Fractions 
with tRNA”’ acceptance activity were concentrated and desalted on 
a small column of DEAE-Sepharose CL-6B (Pharmacia) and precipi- 
tated with ethanol. 
sor tRNA”“’ were each constructed from 7 overlapping 
oligonucleotides. Each tRNA gene sequence was 
flanked by an EcoRI cohesive-end at the 5’-end and a 
PstI cohesive-end at the 3’-end. The oligonucleotides 
were annealed and ligated into the EcoRIIPstI site of the 
plasmid pGFIB-I. This vector contains a synthetic pro- 
moter and a synthetic transcriptional terminator that 
provides the tRNA with functional 3’- and 5’-ends to 
avoid problems of extremity maturation. Since modify- 
ing enzymes can recognize both the sequence surround- 
ing the nucleotide to be modified and the three dimen- 
sional structure [15], it was anticipated that these con- 
structs would produce fully modified functional tRNA. 
After ligation the reaction mixture was digested by 
SnzaI to eliminate reconstructed vector molecules and 
used to transform competent TGI cells. With the ex- 
pression vector pGFIB-I (used for suppressor tRNA”“’ 
only) no positive clones were obtained. We considered 
that this might be due to a lethal effect of the overex- 
pression of the suppressor tRNA. To verify this hypoth- 
esis we cloned the gene into the EcoRIIP.stI site of 
pUC19 (opposite to the direction of transcription from 
the lac promotor) to produce a non-functional tran- 
script and to avoid instability due to gene expression. 
Plasmid DNA sequencing showed that, in this instance, 
we obtained an insert with the correct sequence. This 
was then cloned into a modified expression vector ob- 
tained by deleting the lpp promotor of pGFIB-I and 
replacing it by a synthetic weaker promotor based on 
the trc promotor (Tat 17) sequence [ 161 which had been 
constructed from four overlapping oligonucleotides. 
This promotor has, in contrast to Tat 16 only one pos- 
sible transcriptional initiation site [ 171. 
At the 5’-end of the fragment a NurI restriction site 
was created and the last 4 bases at the 3’-end were 
cloned into the SrnaI site of pUCl9. The resulting plas- 
mid was digested by BalnHI and then partially digested 
modified to create an EcoRI site in order to keep +I of 
the tRNA transcript in the correct position. This gave 
the plasmid pGTRC (Fig. 1). Overexpression of these 
constructs was tested by comparing the serine-specific 
acceptance activity of crude tRNA extracts, with an 
internal standard (valylation of tRNA’“‘). Only a low 
level of overexpression was observed for tRNA,““’ and 
suppressor tRNA”“‘. The plasmid was very unstable. 
less than 1% plasmid-containing cells in an overnight 
culture. To avoid these stability problems, probably due 
to the overexpression from a multi-copy plasmid, we 
recloned the insert containing promoter-gene-termina- 
tor in pOU7 1; a runaway replication plasmid. The clon- 
ing of this DNA fragment was done in two steps. First 
plasmid pGTRC was digested by PvuII, generating a 
300-bp blunt-ends fragment. This fragment was then 
2.6. Aminoaeylation assqs 
The reaction nuxture (50 ~1) contained 63 mM Tris, 50 mM HCl, 
10 mM MgCl,, 0 5 mM DTT. 2.25 mM ATP, pH 7.6, 20 pglml 
SRSEC, 0.1 mM [‘4C]senne (50 mCi/mmol) and tRNA fraction. Incu- 
bation was 15 min at 37°C. and the reaction was stopped by the 
addition of 40 ~1 mixture to a Whatman GF/A filter prewetted with 
20 ~1 TCA. Filters were washed 3 times with 5% TCA, once with 
ethanol. once with ethanol/ether and finally ether. then dned and 
counted. 
2.7. Sequencing of tRNA 
Purified tRNA (3 pug) was 3’-end labelled with [3’P]pCp using T4 
RNA ligase [13]. The radioactive tRNA was separated from non- 
incorporated nucleotide with Nuctrap push columns (Stratagene). The 
tRNA was subjected to enzymatic sequencing as described previously 
[141. 
3. RESULTS AND DISCUSSION 
by EcoRI. The longest fragment was isolated by electro- 
phoresis on agarose gel and cloned in the unique EcoRI/ 
BarnHI sites of pOU71 to give pOTSer2 and pOTSupD 
(Fig. 1). The orientation of the insert in pUC19, and 
3.1. Gene construction and overexpression 
The synthetic genes for tRNA,Fe’ and amber suppres- 
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1 * 2 3 
AATTCGGAGAGATGCCGGAGCGGCTGAACGGACC GTCTCGAAAACCGGAGTAGGGGCAACTCTACCGGG/GGTTCAAATCCCCCTCTCTCCGCCACTGCA 




Fig. I. Construction of a tRNA”“’ OverexpressIng plasmtd. The lpp promotor is replaced by the 7k promotor construct from 4 ollgonu~leotides 
(i’, 3’, 3’, 4’), cloned in Na&‘EcoRI site of pGFIB-I, to gtve pGTrc plasmid. The tRNA gene ts cloned GoRliP~ri between the Trc promotor and 
the rune terminator. A PvztIl 300-bp fragment from pGTrc was recloned mto the &WI sate of pUCl9. The vector pUC19 IS then digested by 
EcoRIILkmHI and the new fragment IS inserted mto EwRIIBLz~PzHI cloning sites of pOU71 to give pOTSer2 or pOTSupD. 
(*Difference between the two tRNAs: the central base of the anticodon m the amber suppressor IS a U.) 
after in pOU71, was not determined since the fragment 
contains a complete transcriptional unit producing a 
tRNA transcript whatever the orientation. 
The plasmid pOU71 contains the 2P, promotor con- 
trolling expression of the replication control genes. In 
addition the plasmid contains the MS57 gene with its 
PM promotor coding for the temperature sensitive h 
repressor. The product of the cf gene controls the activ- 
ity of the hP, promotor. By increasing the temperature 
the /1P, promotor can be easily derepressed, allowing 
high expression of the replication control genes, With 
this construct below 37”C, the plasmid is present at one 
copy per chromosome, whereas at 42°C the replication 
of plasmid DNA becomes uncontrolled. After l-2 h 
induction, 50% of the total DNA in the cell is plasmid, 
corresponding to more than 1,000 plasmid molecules/ 
164 
cell. With the plasmids pOTSer2 and pOTSupD expres- 
sion of the cloned tRNA gene was inhibited at 37°C but 
was very high at 44°C. This tRNA expression system 
is stable at 37°C and allows at 44°C the production of 
total tRNA containing 20 times more tRNA”“* than 
non-induced cells. 
Using the constructs described above 15 mg of tRNA 
could be obtained from 45 g of bacterial paste with a 
specific activity for tRNA”’ of about 1,100 pmol/A,,, 
unit as measured by aminoacylation assays (Table I). 
PAGE/urea analysis of tRNA from induced and non- 
induced cultures (Fig. 2) showed the appearance of a 
band in the induced sample with an h4, corresponding 
to the size of tRNAlqer or amber suppressor tRNA”“. 
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Fig. 2. Purification of E. coli tRNA,er. 10% urea/polyacrylamide gel 
electrophoresis of purificatton fractions stained with ‘Stains All’. Lane 
1: E. coli tRNA’“’ from Boehringer (activity: 1,100 pmol valine/A?,, 
unit): lane 2. unfractionated tRNA from an overproducing construct 
without induction (37’C); lane 3. unfractionated tRNA prepared from 
induced culture (2 h at 43°C); lane 4. pool from BAPPS fractionation; 
lane 5 and 6, pool from FPLC phenyl-Sepharose by hydrophobic 
interaction chromatography (peaks 1 and 2 respectively); lane 7, E. 
colr tRNAs”‘- [20]. 
The first step in the fractionation by anion-exchange 
chromatography on BAPPS is very efficient due to the 
high affinity of tRNAT for this matrix. Typically 
about 80 mg of tRNAZS”’ with an acceptor activity of 
700 pmol/ A,,, unit can be obtained from 330 mg of 
unfractionated tRNA. The second chromatography 
step of hydrophobic interaction on phenyl-Superose 
Table I 
Purification of E. co/l tRNAp 
Yield Acceptor activity 
pmol/ODz,, 
% Purrty 
Crude extract 330 mg 250 19 
BAPPS 79 mg 714 55 
FPLC Peak 1 8 mg 1,105 86 
Peak 2 9 mg 1,190 92 
The crude extract was obtained from 45 g of induced cell paste. The 
acceptor activity was measured by the formatton of [‘4C]Ser-tRNA. 
The purity was estimated by comparing the measured acceptance 
activity of each pool to the theoretical maxtmum acttvity of the 
tRNA,Se’. This maximal activity is determined by using a value of 
30,900 as MW for the tRNA2”’ and an AZ6” of 1 for 40 pg of tRNA. 
60 pm IRNA Ser 
____.___ 
Fig. 3. Preparative scale separation of 20 mg tRNA from BAPPS by 
hydrophobic interaction chromatography on a phenyl-Superose HR 
lO/lO FPLC column. Reverse ammonium sulfate (m 10 mM ammo- 
nium acetate, pH 6.5) gradient from 1.8 M to 1.25 M at a flow rate 
of 0.8 ml/min. 
produced two major peaks with tRNA”” acceptance 
activity (Fig. 3). Material from these two peaks has 
approximately the same specific activity of about 1,100 
pmo1/A26,, units and analysis by PAGE showed that the 
species present in each peak had the same M,.. Since the 
relative area of the second peak increased when the rate 
of expression was lowered (induction at 40°C) we con- 
sidered the possibility that the difference in chromato- 
graphic behaviour was due to variation in the modifica- 
tion of bases in the tRNA”” transcripts. (For the amber 
suppressor the same purification procedure was used 
and we obtained the same results.) 
Consideration of the modified bases of tRNA,“e 
indicated that the probable major effect on the chro- 
matographic behaviour might be due to the modifica- 
tion of A37 by 2 methylthio-N6-isopentenyl-adenosine 
(ms2i6A). We think that this modification is sufficient 
to affect the recognition of A37 by RNase U2 or Phy 
M whereas other modifications such as 2-O-methyla- 
tion of guanosine does not interfere with the recognition 
by RNase Tl [18]. Sequence studies of the fractions 
from the phenyl-Superose column indicated that tRNA 
in the first peak was cleaved at residue A37 and tRNA 
from the second was not. We assume that the differ- 
ences in the tRNAZSe’ and in the amber suppressor sepa- 
rated by this chromatographic step is due to modifica- 
tion of A37. These results seem to indicate that tRNA 
overexpressed in vivo from a synthetic gene can be mod- 
ified, but in this process modifying enzymes are limiting. 
The accompanying report describes the crystallization 
of tRNA2=’ in a complex with E. coli seryl-tRNA syn- 
thetase [ 191. 
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